DC
PROF

Diametric Capital’s Profound Medical PROF Stock Holding History

Diametric Capital’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,205
Closed -$82.7K – 379
2025
Q1 		$82.7K Buy
+14,205
New +$98.1K 0.1% 178

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Diametric Capital's PROF Position: Q2 2025 in Review

Diametric Capital sold out of Profound Medical (PROF) in Q2 2025, closing a stake of 14,205 shares — an estimated $82.7K sold.

Diametric Capital first reported a position in PROF in Q1 2025 and held it in 1 quarter. The position peaked at $82.7K in Q1 2025. 44 funds tracked by Wall St. Rank hold PROF as of Q2 2025.

  • Diametric Capital reported no remaining Profound Medical position as of Q2 2025 after selling out during the quarter.
  • Diametric Capital sold 14,205 Profound Medical shares in Q2 2025, an estimated $82.7K.
  • Diametric Capital first reported a position in Profound Medical in Q1 2025 and held it in 1 quarter.
  • Diametric Capital's Profound Medical position peaked at $82.7K in Q1 2025.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q2 2025.

Based on Diametric Capital's 13F filing for Q2 2025, filed 13 Aug 2025.